These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30575329)

  • 21. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Arunachalam A; Li H; Bittoni MA; Camacho R; Cao X; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e783-e799. PubMed ID: 29983370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US.
    Bhattacharya K; Bentley JP; Ramachandran S; Chang Y; Banahan BF; Shah R; Bhakta N; Yang Y
    JAMA Netw Open; 2021 Jul; 4(7):e2116357. PubMed ID: 34241627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown ML; Riley GF; Schussler N; Etzioni R
    Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF.
    Woodward RM; Brown ML; Stewart ST; Cronin KA; Cutler DM
    Cancer; 2007 Dec; 110(11):2511-8. PubMed ID: 17955504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
    Ramsey SD; Howlader N; Etzioni RD; Donato B
    J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012-2021).
    de Nijs K; de Koning HJ; van der Aalst C; Ten Haaf K
    Eur J Cancer; 2024 Sep; 208():114231. PubMed ID: 39047534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Utilization, Survival, and Costs Analysis of Treatment Options for Stage I Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis.
    Mukherjee K; Davisson N; Malik S; Duszak R; Kokabi N
    Acad Radiol; 2022 Feb; 29 Suppl 2():S173-S180. PubMed ID: 34404607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-Attributable Medical Costs for Colorectal Cancer Patients by Phases of Care: What Is the Effect of a Prior Cancer History?
    Mariotto AB; Warren JL; Zeruto C; Coughlan D; Barrett MJ; Zhao L; Yabroff KR
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):22-30. PubMed ID: 32412066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.
    Shih YT; Xu Y; Chien CR; Kim B; Shen Y; Li L; Geynisman DM
    Pharmacoeconomics; 2019 Dec; 37(12):1495-1507. PubMed ID: 31286464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000-2014.
    Tramontano AC; Chen Y; Watson TR; Eckel A; Hur C; Kong CY
    PLoS One; 2020; 15(4):e0231599. PubMed ID: 32287320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma.
    Aly A; Johnson C; Yang S; Botteman MF; Rao S; Hussain A
    J Med Econ; 2019 Jul; 22(7):662-670. PubMed ID: 30836812
    [No Abstract]   [Full Text] [Related]  

  • 34. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase-specific healthcare costs of cervical cancer: estimates from a population-based study.
    Liu N; Mittmann N; Coyte PC; Hancock-Howard R; Seung SJ; Earle CC
    Am J Obstet Gynecol; 2016 May; 214(5):615.e1-615.e11. PubMed ID: 26627729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs of Cancer Care Across the Disease Continuum.
    Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
    Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007-2010 after the 2006 introduction of bevacizumab.
    Du XL; Parikh RC; Lairson DR
    Lung Cancer; 2015 Dec; 90(3):442-50. PubMed ID: 26439736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.
    Dinan MA; Curtis LH; Carpenter WR; Biddle AK; Abernethy AP; Patz EF; Schulman KA; Weinberger M
    J Thorac Oncol; 2014 Apr; 9(4):512-8. PubMed ID: 24736074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
    Riley GF; Potosky AL; Lubitz JD; Kessler LG
    Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.